疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

  t2 W; i+ [! x

Vaccines, 6th Edition

6 R) \, s/ a0 d; Z4 HApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

: }% ~" @# C' I4 V# N& h" }$ Nhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
( d: `8 W6 P: r& D* t
1 Q4 x: ~& `' j5 C. d7 _; oSECTION 1: General aspects of vaccination
1 A short history of vaccination 1
  B# m1 ], e7 H5 M1 A& R* \2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
! ~  h: l# `. H9 B- s; h8 C# Flicensed vaccines 71
7 Passive immunization 80
8 \% t4 s" B6 A3 E5 w8 General immunization practices 88
SECTION 2: Licensed vaccines
  {# U% u! e& p" V+ a9 x- S8 c& Q9 Adenovirus vaccines 113
10 Anthrax vaccines 127
, y3 \$ x7 a6 J+ u% I11 Cholera vaccines 141
12 Diphtheria toxoid 153
2 n. v# }& c9 |, v6 R7 t9 o13 Haemophilus influenzae vaccines 167
( z( y: ~* H. D* O6 {" x2 C# W14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
; \5 W( b, u1 ]* G16 Human papillomavirus vaccines 235
" i, y. P" H1 ^9 D$ X0 G17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
( s& k; G- E. _( l; h, R3 Z+ k19 Japanese encephalitis vaccines 312
, I7 T; c; b: d# I$ H20 Measles vaccines 352
21 Meningococcal vaccines 388
8 f4 W5 p* [( F. g  G" }" j22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
3 |3 f, H  i* s6 S6 O! L3 M& A28 Poliovirus vaccine-live 598
# e: \# z  `2 y4 k2 p29 Rabies vaccines .646
30 Rotavirus vaccines . 669
9 h2 ~0 m2 i: d! `6 M: X31 Rubella vaccine 688
32 Smallpox and vaccinia 718
* C; ^$ c7 @/ V7 `6 m* U33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
$ C. s1 V8 v" U4 M& g/ f35 Tuberculosis vaccines 789
' I0 ~6 j( k( a& z' y, w36 Typhoid fever vaccines 812
" B; }% l7 ~7 j% v( w9 p) @37 Varicella vaccine 837
38 Yellow fever vaccine 870
& i1 S0 t5 x8 M39 Zoster vaccine 969
40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
6 k/ s3 X- ^! m, r( p7 `41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
+ o3 c/ Z9 a2 k* G( b4 p46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
$ k% u# b( k5 J+ Q# w1 a! g5 d& b50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
& H" ?- u" c( j53 Malaria vaccines 1133
3 k, R1 C9 z5 v54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
1 S" L9 Q( L, S( _. b9 R56 Parasitic disease vaccines 1154
4 Y/ \+ n; r9 H) h57 Staphylococcus aureus vaccines 1161
& g" B! e$ |9 g* j% ^* |58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
# o8 e' X/ m) y& ?1 U5 h! e61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
6 K, v' ?9 p/ F, l+ A% `SECTION 4: Vaccination of special groups
0 B3 b- C2 w* s, `+ k63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
# L: {4 b4 Q3 V2 b0 [: S65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
1 O  G* V& v- d. k+ ISECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
3 D' I, g2 i9 e) A0 h5 q* Z% D68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
2 K+ o) m* u6 w/ }% G2 Z1 |70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
0 l3 j: y; C1 m2 J: @74 Regulation of vaccines in Europe 1447
  S, J# r5 U* f8 E0 J- l75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
* A! |/ E# [* m" d& K77 Legal issues . 1481
78 Ethics 1508


/ ~1 P) p6 V9 e

/ O/ }" A' b  x& K/ d

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link? ... 1&uk=3810996606
+ d, L' C' d7 p& T6 v
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
# a! R( E3 J5 u( f' w2 X3 The vaccine industry 33
+ [: o* u/ ~; p, s4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
$ G, b) Y* Y6 o# i4 b6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
6 ]  {- N) ~5 H3 l5 J7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
; V$ r% d: m! }) y9 Adenovirus vaccines 113
) Z: P5 R1 U/ v- e  I10 Anthrax vaccines 127
' i* O$ W" A$ A8 o11 Cholera vaccines 141
  Y& u) _- [6 Q- L12 Diphtheria toxoid 153
3 F" B! Y. ]6 y) @2 k  l% j3 `& o13 Haemophilus influenzae vaccines 167
, a/ y, x; {3 q& L2 O14 Hepatitis A vaccines 183
6 x* O: \% Q8 y. k1 ?15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
& l9 t2 H' P; I) J# J8 J+ m8 x- w1 ^17 Inactivated influenza vaccines 257
- Q# E8 H5 r: H& x4 h18 Influenza vaccine-live 294
+ L+ w/ ?# f* X, D# O# K& L19 Japanese encephalitis vaccines 312
# {5 @; X" _. f, ~: S2 J5 i3 Q+ P) x20 Measles vaccines 352
21 Meningococcal vaccines 388
! H! {9 c: P8 O22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
* P9 {% t% w- E$ g26 Pneumococcal polysaccharide vaccines 542
5 h* L# ], O5 g$ L3 F1 R# F8 G- {# E27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
' F2 P' L* N: Y: r4 d8 P29 Rabies vaccines .646
! s- _8 w5 O1 A; f7 M3 b7 @30 Rotavirus vaccines . 669
/ u7 A2 F3 @: @$ Y; o+ K3 d  Y& x4 J31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
" U0 L8 q1 y7 f1 O: i4 I. ]34 Tick-borne encephalitis virus vaccines 773
  E2 e2 B+ g9 D: e2 N35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
! u6 k4 O  e. i; i" J! E; J( u37 Varicella vaccine 837
  k3 |7 R; ?7 d( o- z" \38 Yellow fever vaccine 870
39 Zoster vaccine 969
1 H) G# I$ n2 p2 W0 K40 Combination vaccines 981
7 P# k) K* O( wSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
. O1 ?* V) I5 x. r* _3 P" E! o42 Therapeutic cancer vaccines 1018
+ q4 P9 v4 E# X43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
7 g" p5 K/ I4 K3 ]3 T7 x& d* w* f46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
* L$ `3 N/ ]& _- S54 Noninfectious disease vaccines 1138
& A4 Z# C9 X4 R8 o1 v55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
5 P* I  S8 u0 h* j. O56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
1 T' A& v4 D* r- |3 [. V- w58 Streptococcus group A vaccines 1169
! N" b- l, N0 `% L, L59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
3 d4 i! m9 |- M6 H$ M$ [SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
  d, a! h! y: S64 Vaccination of human immunodeficiency virus-infected persons 1257
3 m, a( ]# }5 I  ~65 Vaccines for international travel 1270
8 |$ O, f! a; I2 p" \* i: t/ \3 h66 Vaccines for health care personnel 1290
+ j8 t' n, D- ^- vSECTION 5: Public health and regulatory issues
  f5 G$ l; c, r$ b67 Immunization in the United States 1310
68 Immunization in Europe . 1334
0 S6 \  W$ k! k% B7 g" `69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
7 k2 v* m$ l* W5 q/ A71 Community immunity 1395
1 }" K9 K: T. k- s) Q72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
1 X8 p' ]) `0 T, ?: \  T$ H. o" ?& ~$ S74 Regulation of vaccines in Europe 1447
. E0 E  o: t5 u% ~2 A75 Regulation of vaccines in developing countries 1454
1 P% k# v! Z4 [: x- e) _! x76 Vaccine safety 1464
& g) I/ Q# `/ j77 Legal issues . 1481
: J, H2 o- U0 X) n! c  G5 d- C% U+ w& V; {78 Ethics 1508
+ Q7 g: o$ j% k  B

casarett

Vaccines, 6e, 2012
/ T- ]; W3 V) M6 i$ P! o  W- O
Hardcover: 1570 pages
5 [7 z$ @9 D: k1 T9 u  s* L, \' ZPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
3 d) m/ _" p$ H$ k& O6 v' ^ISBN-10: 1455700908
& q& G% a2 \1 F" O9 j' N6 dSize: 52.3mb (original pdf)
' X( i4 H' g" d7 y  `  x
2013 BMA Medical Book Awards Highly Commended in Public Health!
6 d! O8 g! k/ C! \: Q0 T* vApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
8 g" S* H) \" D  g& S5 M# B. Z( VAnalyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
* r% J( j1 x8 H. U9 a2 P% [; TPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
( M2 s( G/ ^5 r* R# M( ZMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
  t" v1 A! l! N3 @. i  g$ }- X
Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
+ M3 z/ I# L  W% I